INVO logo

INVO Bioscience (INVO) Cash From Financing

Annual CFF

$7.39 M
+$6.30 M+578.31%

December 31, 2023

Summary

Performance

1-Year Change

+578.31%

3-Year Change

-46.52%

5-Year Change

+760.66%

15-Year Change

+13438.83%

INVO Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$13.82 M
INVO annual cash flow from financing activities is currently -46.52% below its historical high of $13.82 million

3-Year Low

$1.09 M
INVO annual cash flow from financing activities is currently +578.31% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
INVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
INVO next annual earnings announcement has not yet been scheduled

OtherINVOcash flowmetrics:

Annual CFI

-$2.49 M
INVO annual cash flow from investing activities is -$2.49 million

Annual CFO

-$4.76 M
INVO annual cash flow from operations is -$4.76 million

Annual FCF

-$5.20 M
INVO annual free cash flow is -$5.20 million

Annual CAPEX

$444.70 K
INVO annual capital expenditures is $444.70 thousand

Quarterly CFF

$169.46 K
-$1.76 M-91.21%

September 30, 2024

Summary

Performance

3-Month Change

-91.21%

1-Year Change

-67.87%

3-Year Change

-46.2%

5-Year Change

-46.2%

INVO Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.11 M
INVO quarterly cash flow from financing activities is currently -98.47% below its historical high of $11.11 million

3-Year Low

-$169.90 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
INVO next earnings announcement has not yet been scheduled

OtherINVOcash flowmetrics:

Quarterly CFI

$0.00
INVO quarterly cash flow from investing activities is $0.00

Quarterly CFO

-$640.81 K
INVO quarterly cash flow from operations is -$640.81 thousand

Quarterly FCF

-$640.81 K
INVO quarterly free cash flow is -$640.81 thousand

Quarterly CAPEX

-
INVO quarterly capital expenditures value is unknown

TTM CFF

$2.48 M
-$4.28 M-63.27%

September 30, 2024

Summary

Performance

3-Month Change

-63.27%

1-Year Change

-46.75%

3-Year Change

-33.15%

5-Year Change

-33.15%

INVO TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$14.19 M
INVO TTM cash flow from financing activities is currently -82.50% below its historical high of $14.19 million

3-Year Low

$1.09 M
INVO TTM cash flow from financing activities is currently +127.93% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
INVO next earnings announcement has not yet been scheduled

OtherINVOcash flowmetrics:

TTM CFI

$4100.00
INVO TTM cash flow from investing activities is $4100.00

TTM CFO

-$3.07 M
INVO TTM cash flow from operations is -$3.07 million

TTM FCF

-$3.25 M
INVO TTM free cash flow is -$3.25 million

TTM CAPEX

-
INVO TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

INVO Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+578.3%-67.9%-46.8%
3 y3 years-46.5%-46.2%-33.1%
5 y5 years+760.7%-46.2%-33.1%

INVO Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-85.3%-96.2%-200.3%-70.2%-56.1%
5 y5-year-46.5%-103.1%-98.5%-200.3%-82.5%-109.2%
alltimeall time-46.5%-103.1%-98.5%-214.8%-82.5%-111.3%

INVO Bioscience Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$169.46 K(-91.2%)
$2.48 M(-63.3%)
Jun 2024
-
$1.93 M(+265.7%)
$6.76 M(+45.0%)
Mar 2024
-
$527.40 K(-472.7%)
$4.66 M(-36.9%)
Dec 2023
$7.39 M(+578.3%)
-$141.50 K(-103.2%)
$7.39 M(-11.3%)
Sep 2023
-
$4.45 M(-2718.4%)
$8.33 M(+115.9%)
Jun 2023
-
-$169.90 K(-105.2%)
$3.86 M(-4.2%)
Mar 2023
-
$3.25 M(+306.9%)
$4.03 M(+269.8%)
Dec 2022
$1.09 M(-71.1%)
$800.00 K(-3274.6%)
$1.09 M(-70.5%)
Sep 2022
-
-$25.20 K(<-9900.0%)
$3.69 M(-0.7%)
Jun 2022
-
$0.00(-100.0%)
$3.72 M(0.0%)
Mar 2022
-
$315.00 K(-90.7%)
$3.72 M(-1.5%)
Dec 2021
$3.77 M(-72.7%)
$3.40 M(>+9900.0%)
$3.77 M(-67.1%)
Sep 2021
-
$0.00(0.0%)
$11.48 M(-3.4%)
Jun 2021
-
$0.00(-100.0%)
$11.88 M(-16.3%)
Mar 2021
-
$369.80 K(-96.7%)
$14.19 M(+2.7%)
Dec 2020
$13.82 M(-6122.5%)
$11.11 M(+2637.6%)
$13.82 M(+409.0%)
Sep 2020
-
$405.70 K(-82.4%)
$2.72 M(+19.4%)
Jun 2020
-
$2.31 M(>+9900.0%)
$2.27 M(-6598.6%)
Mar 2020
-
$0.00(0.0%)
-$35.00 K(-84.7%)
Dec 2019
-$229.50 K(-126.7%)
$0.00(-100.0%)
-$229.50 K(-11.6%)
Sep 2019
-
-$35.00 K(<-9900.0%)
-$259.50 K(-7.2%)
Jun 2019
-
$0.00(-100.0%)
-$279.60 K(-145.3%)
Mar 2019
-
-$194.50 K(+548.3%)
$617.40 K(-28.1%)
Dec 2018
$858.90 K(+1473.1%)
-$30.00 K(-45.6%)
$858.90 K(-4.4%)
Sep 2018
-
-$55.10 K(-106.1%)
$898.90 K(-10.0%)
Jun 2018
-
$897.00 K(+1808.5%)
$998.60 K(+882.9%)
Mar 2018
-
$47.00 K(+370.0%)
$101.60 K(+86.1%)
Dec 2017
$54.60 K
$10.00 K(-77.6%)
$54.60 K(+22.4%)
Sep 2017
-
$44.60 K(>+9900.0%)
$44.60 K(>+9900.0%)
Jun 2017
-
$0.00(0.0%)
$0.00(0.0%)
DateAnnualQuarterlyTTM
Mar 2017
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2016
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 2016
-
$0.00(-100.0%)
$480.00 K(-23.2%)
Dec 2015
$625.00 K(+3025.0%)
$480.00 K(+700.0%)
$625.00 K(+331.0%)
Sep 2015
-
$60.00 K(0.0%)
$145.00 K(+70.6%)
Jun 2015
-
$60.00 K(+140.0%)
$85.00 K(+240.0%)
Mar 2015
-
$25.00 K(-152.0%)
$25.00 K(-76.3%)
Dec 2014
$20.00 K(-71.7%)
-
-
Dec 2013
$70.70 K(+41.4%)
-
-
Dec 2012
$50.00 K(-52.7%)
-
-
Dec 2011
$105.70 K(-57.6%)
-$48.10 K(-194.7%)
$105.60 K(+153.2%)
Sep 2011
-
$50.80 K(+7.9%)
$41.70 K(-70.3%)
Jun 2011
-
$47.10 K(-15.6%)
$140.50 K(-29.1%)
Mar 2011
-
$55.80 K(-149.8%)
$198.30 K(-20.5%)
Dec 2010
$249.50 K(-74.8%)
-$112.00 K(-174.9%)
$249.50 K(-50.1%)
Sep 2010
-
$149.60 K(+42.6%)
$499.50 K(-42.5%)
Jun 2010
-
$104.90 K(-2.0%)
$868.90 K(+5.7%)
Mar 2010
-
$107.00 K(-22.5%)
$822.00 K(-17.0%)
Dec 2009
$990.00 K(-14.4%)
$138.00 K(-73.4%)
$990.00 K(-50.4%)
Sep 2009
-
$519.00 K(+794.8%)
$2.00 M(+50.9%)
Jun 2009
-
$58.00 K(-78.9%)
$1.32 M(-7.1%)
Mar 2009
-
$275.00 K(-76.0%)
$1.42 M(+23.1%)
Dec 2008
$1.16 M(>+9900.0%)
$1.14 M(-842.5%)
$1.16 M(+8862.8%)
Sep 2008
-
-$154.00 K(-196.7%)
$12.90 K(-92.4%)
Jun 2008
-
$159.30 K(+2052.7%)
$170.50 K(+1422.3%)
Mar 2008
-
$7400.00(+3600.0%)
$11.20 K(+194.7%)
Dec 2007
$3800.00(-74.3%)
$200.00(-94.4%)
$3800.00(+5.6%)
Sep 2007
-
$3600.00(>+9900.0%)
$3600.00(>+9900.0%)
Jun 2007
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2007
-
$0.00
$0.00
Dec 2006
$14.80 K
-
-

FAQ

  • What is INVO Bioscience annual cash flow from financing activities?
  • What is the all time high annual CFF for INVO Bioscience?
  • What is INVO Bioscience annual CFF year-on-year change?
  • What is INVO Bioscience quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for INVO Bioscience?
  • What is INVO Bioscience quarterly CFF year-on-year change?
  • What is INVO Bioscience TTM cash flow from financing activities?
  • What is the all time high TTM CFF for INVO Bioscience?
  • What is INVO Bioscience TTM CFF year-on-year change?

What is INVO Bioscience annual cash flow from financing activities?

The current annual CFF of INVO is $7.39 M

What is the all time high annual CFF for INVO Bioscience?

INVO Bioscience all-time high annual cash flow from financing activities is $13.82 M

What is INVO Bioscience annual CFF year-on-year change?

Over the past year, INVO annual cash flow from financing activities has changed by +$6.30 M (+578.31%)

What is INVO Bioscience quarterly cash flow from financing activities?

The current quarterly CFF of INVO is $169.46 K

What is the all time high quarterly CFF for INVO Bioscience?

INVO Bioscience all-time high quarterly cash flow from financing activities is $11.11 M

What is INVO Bioscience quarterly CFF year-on-year change?

Over the past year, INVO quarterly cash flow from financing activities has changed by -$357.94 K (-67.87%)

What is INVO Bioscience TTM cash flow from financing activities?

The current TTM CFF of INVO is $2.48 M

What is the all time high TTM CFF for INVO Bioscience?

INVO Bioscience all-time high TTM cash flow from financing activities is $14.19 M

What is INVO Bioscience TTM CFF year-on-year change?

Over the past year, INVO TTM cash flow from financing activities has changed by -$2.18 M (-46.75%)